Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search


Learn New Tricks: Autocoding Technology is Here and Now
April 29, 2004
If a technical application existed that coded litigation documents at a fraction of the time and cost, would you use it? As new technologies emerge, Winston & Strawn, a 150 year-old firm with nearly 900 attorneys and multiple offices worldwide, asks this question time and again. As litigation support project manager at the Washington, DC office, my latest conclusion is that autocoding is an important piece of litigation technology and the time has come.
e-Discovery Docket Sheet
April 29, 2004
Recent court rulings in e-discovery.
Litigation Cost Control in the Digital Age
April 29, 2004
With new judicial opinions being issued every month on the topic, the allocation of e-discovery costs is probably one of the fastest-growing areas in e-discovery jurisprudence. <br>Given that the price tag associated with e-discovery can be staggering, some of the most intense arguments in a lawsuit can ensue over which party will foot the bill to collect, restore, process and produce the enormous volumes of electronic evidence that is discoverable in many of today's legal proceedings.
Selecting an e-Discovery Provider That Meets Your Needs
April 29, 2004
The potential size of today's data sets, the ease with which electronic files can be altered and the complexity of these projects in general makes selecting the right e-discovery provider a high-stakes game.
The Litigation Balancing Act
April 29, 2004
The principles of "you get what you measure" and "you cannot manage what you cannot measure" seem self-evident. And, to be sure, in most large commercial and public-sector entities, integrated performance-management systems have evolved into foundational elements that support how these organizations are run. <br>But it seems odd that one of the highest-risk and highest-exposure ' and politically and economically sensitive ' business processes has escaped proper measurement: litigation response.
Case Briefing
April 27, 2004
The latest rulings of importance to you and your practice.
California's Prop 65 Trumped By FDA, But On Narrow Grounds
April 27, 2004
The truth is apparently no defense for the state when it comes to issuing warning labels for nicotine gums and patches. Recently, the California Supreme Court unanimously ruled in <i>Dowhal v. SmithKline Beecham Consumer Healthcare</i>, 04 C.D.O.S. 3259 that federal regulations trump state statutes when it comes to putting pregnant women on alert about the possible dangers of Nicorette' and other nicotine-replacement therapies -- even if the state warnings are legitimate. "Whether a label is potentially misleading or incomprehensible is essentially a judgment of how the consumer will respond to the language of the label," Justice Joyce Kennard wrote. "A truthful warning of an uncertain or remote danger may mislead the consumer into misjudging the dangers stemming from the use of the product, and consequently making a medically unwise decision."
Pharmaceutical Benefits Managers Get Reprieve in Maine
April 27, 2004
In a decision issued March 9 in the case of <i>Pharmaceutical Care Management Ass'n v. Rowe</i>, No. 03-153-B-W, 2004 U.S. Dist. LEXIS 3758 (D. Maine 3/9/04), U.S. District Judge John A. Woodcock Jr. delayed enforcement of a novel Maine law whose intent is to make the business practices of companies that negotiate drug prices on behalf of health plans more transparent. The preliminary injunction has at least temporarily prevented the state of Maine from implementing Maine's 2003 "Act to Protect Against Unfair Prescription Drug Practices (M.R.S.A. ' 2699), known as UPDPA, against pharmaceutical benefits managers (PBMs).
News from the FDA
April 27, 2004
The most recent news from the agency.
The 'New Normal': SARS Liability Implications
April 27, 2004
Without disease and illness, there would be no need for life science companies or the products that they develop. Some modern maladies and ailments present more challenges than opportunities for biotech and medical device firms. Severe Acute Respiratory Syndrome (SARS) and comparable pathogens present medical device and life science manufacturers with new and daunting risks. One such peril lies in the realm of product liability.

MOST POPULAR STORIES

  • Major Differences In UK, U.S. Copyright Laws
    This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
    Read More ›
  • Legal Possession: What Does It Mean?
    Possession of real property is a matter of physical fact. Having the right or legal entitlement to possession is not "possession," possession is "the fact of having or holding property in one's power." That power means having physical dominion and control over the property.
    Read More ›
  • The Stranger to the Deed Rule
    In 1987, a unanimous Court of Appeals reaffirmed the vitality of the "stranger to the deed" rule, which holds that if a grantor executes a deed to a grantee purporting to create an easement in a third party, the easement is invalid. Daniello v. Wagner, decided by the Second Department on November 29th, makes it clear that not all grantors (or their lawyers) have received the Court of Appeals' message, suggesting that the rule needs re-examination.
    Read More ›